Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D George

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
JAMA|May 4, 2021
Treatment Strategies for Patients With Immune-Mediated Inflammatory DiseasesJeffrey R Curtis, Alexis Ogdie, Michael D George
Current Opinion in HIV and AIDS|June 15, 2010
Th17 cells, HIV and the gut mucosal barrierSatya Dandekar, Michael D George, Andreas J Bäumler
Medicine|August 19, 2016
Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal rangeMichael D George, Neilia-Kay McGill, Joshua F Baker
Clinical and Experimental Rheumatology|February 24, 2017
Choice of second biologic in rheumatoid arthritis patients with inadequate response to initial anti-TNFPrateek C Gandiga, Michael D George, Joshua F Baker
Journal of Virology|February 15, 2005
Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regenerationMichael D George, Elizabeth Reay, Sumathi Sankaran, et al.
Clinical Rheumatology|January 27, 2022
Association between depression, anxiety, chronic pain, or opioid use and tumor necrosis factor inhibitor persistence in inflammatory arthritisGuy Katz, Alexis Ogdie, Joshua F Baker, et al.
Annals of Internal Medicine|November 5, 2019
Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing ArthroplastyMichael D George, Joshua F Baker, Kevin Winthrop, et al.
ACR Open Rheumatology|June 30, 2022
Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical TrialsAnthony J Cordisco, Marianna Olave, Michael D George, et al.
Clinical and Experimental Rheumatology|April 18, 2020
Association between antinuclear antibody seropositivity and telomere length: a nationwide population-based studyJake G Natalini, Michael D George, Steven M Kawut, et al.
Virology|August 2, 2003
High-throughput gene expression profiling indicates dysregulation of intestinal cell cycle mediators and growth factors during primary simian immunodeficiency virus infectionMichael D George, Sumathi Sankaran, Elizabeth Reay, et al.
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
JAMA|May 4, 2021
Treatment Strategies for Patients With Immune-Mediated Inflammatory DiseasesJeffrey R Curtis, Alexis Ogdie, Michael D George
Current Opinion in HIV and AIDS|June 15, 2010
Th17 cells, HIV and the gut mucosal barrierSatya Dandekar, Michael D George, Andreas J Bäumler
Medicine|August 19, 2016
Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal rangeMichael D George, Neilia-Kay McGill, Joshua F Baker
Clinical and Experimental Rheumatology|February 24, 2017
Choice of second biologic in rheumatoid arthritis patients with inadequate response to initial anti-TNFPrateek C Gandiga, Michael D George, Joshua F Baker
Journal of Virology|February 15, 2005
Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regenerationMichael D George, Elizabeth Reay, Sumathi Sankaran, et al.
Clinical Rheumatology|January 27, 2022
Association between depression, anxiety, chronic pain, or opioid use and tumor necrosis factor inhibitor persistence in inflammatory arthritisGuy Katz, Alexis Ogdie, Joshua F Baker, et al.
Annals of Internal Medicine|November 5, 2019
Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing ArthroplastyMichael D George, Joshua F Baker, Kevin Winthrop, et al.
ACR Open Rheumatology|June 30, 2022
Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical TrialsAnthony J Cordisco, Marianna Olave, Michael D George, et al.
Clinical and Experimental Rheumatology|April 18, 2020
Association between antinuclear antibody seropositivity and telomere length: a nationwide population-based studyJake G Natalini, Michael D George, Steven M Kawut, et al.
Virology|August 2, 2003
High-throughput gene expression profiling indicates dysregulation of intestinal cell cycle mediators and growth factors during primary simian immunodeficiency virus infectionMichael D George, Sumathi Sankaran, Elizabeth Reay, et al.
Pageof 13